June 15, 2020 / 1:03 PM / 24 days ago

BRIEF-Ardelyx Announces Positive Second Data Analysis From Normalize Phase 4 Study Evaluating Tenapanor In CKD Patients On Dialysis

June 15 (Reuters) - Ardelyx Inc:

* ARDELYX ANNOUNCES POSITIVE SECOND DATA ANALYSIS FROM ONGOING NORMALIZE PHASE 4 STUDY EVALUATING TENAPANOR IN CKD PATIENTS ON DIALYSIS

* ARDELYX - TENAPANOR PARTNER IN JAPAN PRESENTED PHASE 2 DATA AT ERA-EDTA DEMONSTRATING TENAPANOR ENABLED SIGNIFICANT REDUCTION IN OVERALL PILL BURDEN

* ARDELYX INC - NDA SUBMISSION FOR TENAPANOR FOR CONTROL OF SERUM PHOSPHORUS ON-TRACK FOR MID-2020 Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below